A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

Publication Title

SITC 2021

Authors

• David B Page, Providence Cancer Center, Earle A. Chiles Research Institute Portland , OR , USAFollow
• Krystle Collins
• Brie Chun, Earle A. Chiles Research Institute, 4805 N.E. Glisan St., North Tower, Suite 2N87, Portland, OR, 97213, USA.Follow
• Zhaoyu Sun, Earle A. Chiles Research Institute, Providence Portland Medical CenterFollow
• Yoshinobu Koguchi, Robert W Franz Cancer Center, Earle A Chiles Research Institute, Portland, OR, USAFollow
• William D Ryan, Department of Pathology, Providence St. Vincent Medical Center, Portland, OR, USA.Follow
• Maritza Martel, Providence Portland Medical Center, Portland, ORFollow
• Yaping Wu, Pathology, Providence Portland Medical CenterFollow
• Nikki Moxon, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, ORFollow
• Staci Mellinger, Earle A. Chiles Research Institute, Portland, OR; Providence Cancer Institute, Portland, ORFollow
• Walter Urba, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, 97213, USA.Follow
• Ayca Gucalp
• Tiffany A. Traina

Document Type

Article

Publication Date

2021

Keywords

oregon; washington; chiles

Area of Special Interest

Cancer

Area of Special Interest

Women & Children

Specialty/Research Institute

Earle A. Chiles Research Institute

Specialty/Research Institute

Oncology